BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 12600880)

  • 41. A peptide antagonist of thrombospondin-1 promotes abdominal aortic aneurysm progression in the angiotensin II-infused apolipoprotein-E-deficient mouse.
    Krishna SM; Seto SW; Jose RJ; Biros E; Moran CS; Wang Y; Clancy P; Golledge J
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):389-98. PubMed ID: 25524772
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia.
    Zhang LN; Vincelette J; Cheng Y; Mehra U; Chen D; Anandan SK; Gless R; Webb HK; Wang YX
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1265-70. PubMed ID: 19667112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of angiotensin II on the coupled microstructural and biomechanical response of C57BL/6 mouse aorta.
    Haskett D; Speicher E; Fouts M; Larson D; Azhar M; Utzinger U; Vande Geest J
    J Biomech; 2012 Mar; 45(5):772-9. PubMed ID: 22196971
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High serum thrombospondin-1 concentration is associated with slower abdominal aortic aneurysm growth and deficiency of thrombospondin-1 promotes angiotensin II induced aortic aneurysm in mice.
    Krishna SM; Seto SW; Jose R; Li J; Moxon J; Clancy P; Crossman DJ; Norman P; Emeto TI; Golledge J
    Clin Sci (Lond); 2017 Jun; 131(12):1261-1281. PubMed ID: 28364044
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Macrophage-targeted overexpression of urokinase causes accelerated atherosclerosis, coronary artery occlusions, and premature death.
    Cozen AE; Moriwaki H; Kremen M; DeYoung MB; Dichek HL; Slezicki KI; Young SG; Véniant M; Dichek DA
    Circulation; 2004 May; 109(17):2129-35. PubMed ID: 15096455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.
    Heymans S; Pauschinger M; De Palma A; Kallwellis-Opara A; Rutschow S; Swinnen M; Vanhoutte D; Gao F; Torpai R; Baker AH; Padalko E; Neyts J; Schultheiss HP; Van de Werf F; Carmeliet P; Pinto YM
    Circulation; 2006 Aug; 114(6):565-73. PubMed ID: 16880329
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of apolipoprotein E, age and aortic site on calcium phosphate induced abdominal aortic aneurysm in mice.
    Wang Y; Krishna SM; Moxon J; Dinh TN; Jose RJ; Yu H; Golledge J
    Atherosclerosis; 2014 Jul; 235(1):204-12. PubMed ID: 24858339
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyperhomocysteinemia exaggerates adventitial inflammation and angiotensin II-induced abdominal aortic aneurysm in mice.
    Liu Z; Luo H; Zhang L; Huang Y; Liu B; Ma K; Feng J; Xie J; Zheng J; Hu J; Zhan S; Zhu Y; Xu Q; Kong W; Wang X
    Circ Res; 2012 Oct; 111(10):1261-73. PubMed ID: 22912384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta.
    Shireman PK; McCarthy WJ; Pearce WH; Shively VP; Cipollone M; Kwaan HC
    J Vasc Surg; 1997 Jan; 25(1):157-64. PubMed ID: 9013920
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Dipeptidyl Peptidase-4 Inhibitor but not Incretins Suppresses Abdominal Aortic Aneurysms in Angiotensin II-Infused Apolipoprotein E-Null Mice.
    Kohashi K; Hiromura M; Mori Y; Terasaki M; Watanabe T; Kushima H; Shinmura K; Tomoyasu M; Nagashima M; Hirano T
    J Atheroscler Thromb; 2016; 23(4):441-54. PubMed ID: 26549734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice.
    Ishibashi M; Egashira K; Zhao Q; Hiasa K; Ohtani K; Ihara Y; Charo IF; Kura S; Tsuzuki T; Takeshita A; Sunagawa K
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):e174-8. PubMed ID: 15331433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis.
    Wang YX; Martin-McNulty B; da Cunha V; Vincelette J; Lu X; Feng Q; Halks-Miller M; Mahmoudi M; Schroeder M; Subramanyam B; Tseng JL; Deng GD; Schirm S; Johns A; Kauser K; Dole WP; Light DR
    Circulation; 2005 May; 111(17):2219-26. PubMed ID: 15851596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Group X secretory phospholipase A(2) augments angiotensin II-induced inflammatory responses and abdominal aortic aneurysm formation in apoE-deficient mice.
    Zack M; Boyanovsky BB; Shridas P; Bailey W; Forrest K; Howatt DA; Gelb MH; de Beer FC; Daugherty A; Webb NR
    Atherosclerosis; 2011 Jan; 214(1):58-64. PubMed ID: 20833395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic backgrounds but not sizes of atherosclerotic lesions determine medial destruction in the aortic root of apolipoprotein E-deficient mice.
    Shi W; Brown MD; Wang X; Wong J; Kallmes DF; Matsumoto AH; Helm GA; Drake TA; Lusis AJ
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1901-6. PubMed ID: 12920047
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice.
    Moriwaki H; Stempien-Otero A; Kremen M; Cozen AE; Dichek DA
    Circ Res; 2004 Sep; 95(6):637-44. PubMed ID: 15297377
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Remodelling of the zero-stress state and residual strains in apoE-deficient mouse aorta.
    Gregersen H; Zhao J; Lu X; Zhou J; Falk E
    Biorheology; 2007; 44(2):75-89. PubMed ID: 17538200
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice.
    Gavrila D; Li WG; McCormick ML; Thomas M; Daugherty A; Cassis LA; Miller FJ; Oberley LW; Dellsperger KC; Weintraub NL
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1671-7. PubMed ID: 15933246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deficiency of Endogenous Acute-Phase Serum Amyloid A Protects apoE-/- Mice From Angiotensin II-Induced Abdominal Aortic Aneurysm Formation.
    Webb NR; De Beer MC; Wroblewski JM; Ji A; Bailey W; Shridas P; Charnigo RJ; Noffsinger VP; Witta J; Howatt DA; Balakrishnan A; Rateri DL; Daugherty A; De Beer FC
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1156-65. PubMed ID: 25745063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PPARδ reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice by regulating extracellular matrix homeostasis and inflammatory responses.
    Hwang JS; Kim HJ; Kim G; Kang ES; Ham SA; Yoo T; Paek KS; Yabe-Nishimura C; Kim HJ; Seo HG
    Int J Cardiol; 2014 Jun; 174(1):43-50. PubMed ID: 24698256
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Smooth muscle cell deletion of low-density lipoprotein receptor-related protein 1 augments angiotensin II-induced superior mesenteric arterial and ascending aortic aneurysms.
    Davis FM; Rateri DL; Balakrishnan A; Howatt DA; Strickland DK; Muratoglu SC; Haggerty CM; Fornwalt BK; Cassis LA; Daugherty A
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):155-62. PubMed ID: 25395615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.